Autosomal recessive retinitis pigmentosa (RP), a heterogeneous group of degenerations of the retina, can be due to mutations in the MFRP (membrane-type frizzled-related protein) gene. A patient with RP with MFRP mutations, one of which is novel and the first splice site mutation reported, was characterized by noninvasive retinal and visual studies. The phenotype, albeit complex, suggested that this retinal degeneration may be a candidate for gene-based therapy. Proof-of-concept studies were performed in the rd6 Mfrp mutant mouse model. The fast-acting tyrosine-capsid mutant AAV8 (Y733F) vector containing the small chicken β-actin promoter driving the wild-type mouse Mfrp gene was used. Subretinal vector delivery on postnatal day 14 prevented retinal degeneration. Treatment rescued rod and cone photoreceptors, as assessed by electroretinography and retinal histology at 2 months of age. This AAV-mediated gene delivery also resulted in robust MFRP expression predominantly in its normal location within the retinal pigment epithelium apical membrane and its microvilli. The clinical features of MFRP-RP and our preliminary data indicating a response to gene therapy in the rd6 mouse suggest that this form of RP is a potential target for gene-based therapy.
Get full access to this article
View all access options for this article.
References
1.
AlemanT.S., CideciyanA.V., VolpeN.J.et al.2002. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. Exp. Eye Res., 74:737–745.
2.
AlemanT.S., SoumittraN., CideciyanA.V.et al.2009. CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest. Ophthalmol. Vis. Sci., 50:5944–5954.
3.
AlMahmoudT., PriestD., MungerR., JacksonW.B.2011. Correlation between refractive error, corneal power, and thickness in a large population with a wide range of ametropia. Invest. Ophthalmol. Vis. Sci., 52:1235–1242.
4.
Ayala-RamirezR., Graue-WiechersF., RobredoV.et al.2006. A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation. Mol. Vis., 12:1483–1489.
5.
BijlsmaW.R., van SchooneveldM.J., Van der LelijA.2008. Optical coherence tomography findings for nanophthalmic eyes. Retina, 28:1002–1007.
6.
BonilhaV.L., RaybornM.E., BhattacharyaS.K.et al.2006. The retinal pigment epithelium apical microvilli and retinal function. Adv. Exp. Med. Biol., 572:519–524.
7.
BuysY.M., PavlinC.J.1999. Retinitis pigmentosa, nanophthalmos, and optic disc drusen: A case report. Ophthalmology, 106:619–622.
8.
CarronC., PascalA., DjianeA.et al.2003. Frizzled receptor dimerization is sufficient to activate the Wnt/β-catenin pathway. J. Cell Sci., 116:2541–2550.
9.
CarusoR.C., AlemanT.S., CideciyanA.V.et al.2010. Retinal disease in Rpe65-deficient mice: Comparison to human Leber congenital amaurosis due to RPE65 mutations. Invest. Ophthalmol. Vis. Sci., 51:5304–5313.
10.
CideciyanA.V.2010. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog. Retin. Eye Res., 29:398–427.
11.
CideciyanA.V., SwiderM., AlemanT.S.et al.2007. Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. J. Opt. Soc. Am. A Opt. Image Sci. Vis., 24:1457–1467.
12.
CideciyanA.V., RachelR.A., AlemanT.S.et al.2011. Cone photoreceptors are the main targets for gene therapy of NPHP5 (IQCB1) or NPHP6 (CEP290) blindness: Generation of an all-cone Nphp6 hypomorph mouse that mimics the human retinal ciliopathy. Hum. Mol. Genet., 20:1411–1423.
13.
CrespíJ., BuilJ.A., BassaganyasF.et al.2008. A novel mutation confirms MFRP as the gene causing the syndrome of nanophthalmos–retinitis pigmentosa–foveoschisis–optic disk drusen. Am. J. Ophthalmol., 146:323–328.
14.
DannC.E., HsiehJ.C., RattnerA.et al.2001. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature, 412:86–90.
15.
FogertyJ., BesharseJ.C.2011. 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. Invest. Ophthalmol. Vis. Sci., 52:7256–7266.
16.
FontanaS.T., BrubakerR.F.1980. Volume and depth of the anterior chamber in the normal aging human eye. Arch. Ophthalmol., 98:1803–1808.
17.
GhoseS., SachdevM.S., KumarH.1985. Bilateral nanophthalmos, pigmentary retinal dystrophy, and angle closure glaucoma—a new syndrome?Br. J. Ophthalmol., 69:624–628.
18.
HawesN.L., ChangB., HagemanG.S.et al.2000. Retinal degeneration 6 (rd6): A new mouse model for human retinitis punctata albescens. Invest. Ophthalmol. Vis. Sci., 41:3149–3157.
19.
HaywardC., ShuX., CideciyanA.V.et al.2003. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: A genetic model for age-related macular degeneration. Hum. Mol. Genet., 12:2657–2667.
20.
JacobsonS.G., VoigtW.J., ParelJ.M.et al.1986. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology, 93:1604–1611.
21.
JacobsonS.G., YagasakiK., FeuerW.J., RomanA.J.1989. Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa. Exp. Eye Res., 48:679–691.
22.
JacobsonS.G., CideciyanA.V., WrightE., WrightA.F.2001. Phenotypic marker for early disease detection in dominant late-onset retinal degeneration. Invest. Ophthalmol. Vis. Sci., 42:1882–1890.
23.
JacobsonS.G., CideciyanA.V., SumarokaA.et al.2006. Remodeling of the human retina in choroideremia: Rab escort protein 1 (REP-1) mutations. Invest. Ophthalmol. Vis. Sci., 47:4113–4120.
24.
JacobsonS.G., AlemanT.S., CideciyanA.V.et al.2007. Human cone photoreceptor dependence on RPE65 isomerase. Proc. Natl. Acad. Sci. U.S.A., 104:15123–15128.
25.
JacobsonS.G., RomanA.J., AlemanT.S.et al.2010. Normal central retinal function and structure preserved in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci., 51:1079–1085.
26.
JacobsonS.G., CideciyanA.V., AlemanT.S.et al.2011. Human retinal disease from AIPL1 gene mutations: Foveal cone loss with minimal macular photoreceptors and rod function remaining. Invest. Ophthalmol. Vis. Sci., 52:70–79.
27.
KameyaS., HawesN.L., ChangB.et al.2002. Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. Hum. Mol. Genet., 11:1879–1886.
28.
KatohM.2001. Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein. Biochem. Biophys. Res. Commun., 282:116–123.
29.
KishoreU., GaboriaudC., WatersP.et al.2004. C1q and tumor necrosis factor superfamily: Modularity and versatility. Trends Immunol., 25:551–561.
30.
LeonardK.C., PetrinD., CouplandS.G.et al.2007. XIAP protection of photoreceptors in animal models of retinitis pigmentosa. PLoS One, 2:e314.
31.
LuJ.H., TheB.K., WangL.et al.2008. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell. Mol. Immunol., 5:9–21.
32.
MacKayC.J., ShekM.S., CarrR.E.et al.1987. Retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma: A new recessive syndrome. Arch. Ophthalmol., 105:366–371.
33.
MandalM.N., VasireddyV., JablonskiM.M.et al.2006. Spatial and temporal expression of MFRP and its interaction with CTRP5. Invest. Ophthalmol. Vis. Sci., 47:5514–5521.
34.
MarmorM.F., ChoiS.S., ZawadzkiR.J., WernerJ.S.2008. Visual insignificance of the foveal pit: Reassessment of foveal hypoplasia as fovea plana. Arch. Ophthalmol., 126:907–913.
35.
McAllisterJ.T., DubisA.M., TaitD.M.et al.2010. Arrested development: High-resolution imaging of foveal morphology in albinism. Vision Res., 50:810–817.
36.
MilamA.H., CurcioC.A., CideciyanA.V.et al.2000. Dominant late-onset retinal degeneration with regional variation of sub-retinal pigment epithelium deposits, retinal function, and photoreceptor degeneration. Ophthalmology, 107:2256–2266.
37.
MukhopadhyayR., SergouniotisP.I., MackayD.S.et al.2010. A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy. Mol. Vis., 16:540–548.
38.
OliveiraC., HarizmanN., GirkinC.A.et al.2007. Axial length and optic disc size in normal eyes. Br. J. Ophthalmol., 91:37–39.
39.
PangJ.J., BoyeS.L., KumarA.et al.2008. AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEβ mutation. Invest. Ophthalmol. Vis. Sci., 49:4278–4283.
40.
PangJ.J., DaiX., BoyeS.E.et al.2011. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Mol. Ther., 19:234–242.
41.
PauerG.J., XiQ., ZhangK.et al.2005. Mutation screen of the membrane-type frizzled-related protein (MFRP) gene in patients with inherited retinal degenerations. Ophthalmic Genet., 26:157–161.
42.
Petrs-SilvaH., DinculescuA., LiQ.et al.2009. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol. Ther., 17:463–471.
43.
Petrs-SilvaH., DinculescuA., LiQ.et al.2011. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol. Ther., 19:293–301.
44.
ProvisJ.M., DiazC.M., DreherB.1998. Ontogeny of the primate fovea: A central issue in retinal development. Prog. Neurobiol., 54:549–580.
45.
RomanA.J., SchwartzS.B., AlemanT.S.et al.2005. Quantifying rod photoreceptor-mediated vision in retinal degenerations: Dark-adapted thresholds as outcome measures. Exp. Eye Res., 80:259–272.
46.
RomanA.J., BoyeS.L., AlemanT.S.et al.2007. Electroretinographic analyses of Rpe65-mutant rd12 mice: Developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis. Mol. Vis., 13:1701–10.
47.
RüferF., SchröderA., ArvaniM.K., ErbC.2005. [Central and peripheral corneal pachymetry—standard evaluation with the Pentacam system] [in German]Klin. Monbl. Augenheilkd., 222:117–122.
48.
ShuX., TullochB., LennonA.et al.2006. Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5. Hum. Mol. Genet., 15:1680–1689.
49.
SparrowJ.R., HicksD., HamelC.P.2010. The retinal pigment epithelium in health and disease. Curr. Mol. Med., 10:802–823.
50.
StraussO.2005. The retinal pigment epithelium in visual function. Physiol. Rev., 85:845–881.
51.
SundinO.H.2005. The mouse's eye and Mfrp: Not quite human. Ophthalmic Genet., 26:153–155.
52.
SundinO.H., LeppertG.S., SilvaE.D.et al.2005. Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein. Proc. Natl. Acad. Sci. U.S.A., 102:9553–9558.
53.
SundinO.H., DharmarajS., BhuttoI.A.et al.2008. Developmental basis of nanophthalmos: MFRP is required for both prenatal ocular growth and postnatal emmetropization. Ophthalmic Genet., 29:1–9.
54.
WeymouthA.E., VingrysA.J.2008. Rodent electroretinography: Methods for extraction and interpretation of rod and cone responses. Prog. Retin. Eye Res., 27:1–44.
55.
WonJ., SmithR.S., PeacheyN.S.et al.2008. Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments. Vis. Neurosci., 25:563–574.
56.
ZentenoJ.C., Buentello-VolanteB., Quiroz-GonzalezM.A., Quiroz-ReyesM.A.2009. Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos–retinitis pigmentosa complex. Mol. Vis., 15:1794–1798.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
